A double-blind, randomized, placebo-controlled, phase II study of maintenance enzastaurin with 5-FU/leucovorin plus bevacizumab following first-line therapy for metastatic colorectal cancer (mCRC).
Get the components of the BLMBRG GRAINS INDX (FCGR.EX) to help with your investment decision from Yahoo Finance ...
Efficacy of gemcitabine and cisplatin (GP) as first-line combination therapy in patients with triple-negative metastatic breast cancer: Preliminary results report of a phase II trial. Background: The ...
Get historical data for the BLMBRG GRAINS INDX (FCGR.EX) on Yahoo Finance. View and download daily, weekly or monthly data to help your investment decisions.
Get the basic BLMBRG GRAINS INDX (FCGR.EX) option chain and pricing options for different maturity periods from Yahoo Finance.
Components data is currently not available for FCGR.EX.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results